Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 4530

Max Ratio

Dividend Yield

2.52 %

5Y Dividend Growth

-46.00 %

Consecutive Years

5Y Average Payout Ratio

54.81 %

Dividend History 4530

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 2.52 %
Consecutive Years 0
Forward Annual Dividend 105.00 JPY
Consistent Years 0
Dividend CAGR 3Y -18.78 %
Continuous Dividends
Dividend CAGR 5Y -11.52 %
Payout Ratio TTM 17.45 %
Dividend CAGR 10Y -5.59 %
Ex Dividend Date 08/28/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 4530

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 4530

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 4530

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 4530

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 4530

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Hisamitsu Pharmaceutical Inc 4530

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 4530

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 15.65
Forward PE
Enterprise Value Revenue 1.16
Price Sales TTM 1.87
Enterprise Value EBITDA 5.55
Price Book MRQ 1.09

Hisamitsu Pharmaceutical Inc Dividends: 2.47 % Yield, History, Payment Schedule

4530
Current price
4 166.00 JPY +16.02 JPY (+0.39%)
Last closed 4 150.00 JPY
ISIN JP3784600003
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Tokyo Stock Exchange
Capitalization 296 556 789 776 JPY
Yield for 12 month -1.75 %
1Y
3Y
5Y
10Y
15Y
4530
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+156 006 000 066 JPY

Last Year

+141 705 999 927 JPY

Current Quarter

+34 664 999 986 JPY

Last Quarter

+44 753 000 006 JPY

Current Year

+91 195 999 971 JPY

Last Year

+78 970 999 992 JPY

Current Quarter

+21 285 999 952 JPY

Last Quarter

+24 808 000 055 JPY
EBITDA 24 860 999 715 JPY
Operating Margin TTM 11.83 %
Price to Earnings 15.65
Return On Assets TTM 3.28 %
PEG Ratio
Return On Equity TTM 7.39 %
Wall Street Target Price 671 536.26 JPY
Revenue TTM 155 493 007 360 JPY
Book Value 3 738.99 JPY
Revenue Per Share TTM
Dividend Share 88.00 JPY
Quarterly Revenue Growth YOY 1.60 %
Dividend Yield 2.52 %
Gross Profit TTM 92 879 003 648 JPY
Earnings per share 269.32 JPY
Diluted Eps TTM 269.32 JPY
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 5.70 %
Profit Margin 12.66 %

Technical Indicators 4530

For 52 Weeks

3 742.66 JPY 4 638.09 JPY
50 Day MA 4 155.44 JPY
Shares Short Prior Month
200 Day MA 4 183.33 JPY
Short Ratio
Shares Short
Short Percent